(Q23671266)

Dimensions

8 February 2023

RunHong Li

series ordinal

2

author given names

RunHong

author last names

Li

1 reference

Dimensions

8 February 2023

DaQing Zhang

series ordinal

3

author given names

DaQing

author last names

Zhang

1 reference

Dimensions

Science in China. Series C: Life Sciences

8 February 2023

language of work or name

English

0 references

publication date

6 May 2013

0 references

published in

0 references

volume

56

0 references

issue

6

0 references

page(s)

495-502

0 references

cites work

Treatment of acute granulocytic leukemias

1 reference

https://api.crossref.org/works/10.1007%2FS11427-013-4487-Z

Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-013-4487-Z

How I treat acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-013-4487-Z

Modern approaches to treating acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-013-4487-Z

Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-013-4487-Z

Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-013-4487-Z

Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-013-4487-Z

The role of 13 cis-retinoic acid in the remission induction of a patient with acute promyelocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-013-4487-Z

All-trans-retinoic acid in acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-013-4487-Z

Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-013-4487-Z

Ancient remedy performs new tricks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-013-4487-Z

Arsenic trioxide, a therapeutic agent for APL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-013-4487-Z

How acute promyelocytic leukaemia revived arsenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-013-4487-Z

Acute promyelocytic leukemia: from highly fatal to highly curable

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-013-4487-Z

From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-013-4487-Z

Induction of differentiation of human acute non-lymphocytic leukemia cells in primary culture by inducers of differentiation of human myeloid leukemia cell line HL-60

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-013-4487-Z

7 January 2021

Daunorubicin in the treatment of acute myelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1007%2FS11427-013-4487-Z

7 January 2021

Retinoic acid therapy for promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1007%2FS11427-013-4487-Z

7 January 2021

Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)

1 reference

https://api.crossref.org/works/10.1007%2FS11427-013-4487-Z

7 January 2021

History of the treatment of chronic myelocytic leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS11427-013-4487-Z

7 January 2021

Probable in vivo induction of differentiation by retinoic acid of promyelocytes in acute promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1007%2FS11427-013-4487-Z

7 January 2021

Oral arsenic trioxide-based maintenance regimens for first complete remission of acute promyelocytic leukemia: a 10-year follow-up study

1 reference

https://api.crossref.org/works/10.1007%2FS11427-013-4487-Z

7 January 2021

Newly diagnosed acute promyelocytic leukemia: arsenic moves front and center

1 reference

https://api.crossref.org/works/10.1007%2FS11427-013-4487-Z

7 January 2021

10.1007/S11427-013-4487-Z

Identifiers

DOI

0 references